Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center

Authors:

Hana Skala Kavanagh, Stipe Ćavar, Frane Grubišić, Ines Doko Vajdić, Jadranka Kraljević, Dragan Glavaš, Simeon Grazio

Summary
Sažetak

Vol.: 2024;71(Supl 1/Suppl 1):19-31

https://doi.org/10.33004/reumatizam-supp-71-1-21

Dragan Glavaš, Frane Grubišić, Hana Skala Kavanagh, Ines Doko Vajdić, Jadranka Kraljević, Simeon Grazio, Stipe Ćavar

Preuzmi PDF